Urolithin A

SKU: orb1300010

Description

Urolithin A

Research Area

Cell Biology, Immunology & Inflammation, Metabolism Research, Molecular Biology, Signal Transduction

Key Properties

• CAS Number: 1143-70-0
• MW: 228.2
• Purity: 99.67%
• Formula: C₁₃H₈O₄
• SMILES: Oc1ccc2c(c1)oc(=O)c1cc(O)ccc21
• Target: DNA/RNA Synthesis,Reactive Oxygen Species,Apoptosis,Endogenous Metabolite,Drug Metabolite,Autophagy
• Solubility: DMSO:242.5 mg/mL (1062.66 mM);10% DMSO+40% PEG300+5% Tween 80+45% Saline:5 mg/mL (21.91 mM)

Bioactivity

• Target IC50:
  St-T1b cells:39.88 µM|T24 cells:43.9 μM|Caco-2 cells:49 μM|12Z endometriotic cells:40.46 µM|SW620 cells:53.561 μM|CK2:0.39 𝜇M
• In Vivo:
  METHODS: To investigat the effects on Alzheimer's disease (AD), Urolithin A (300 mg/kg, 0.5% carboxymethylcellulose) was administered orally once daily for 14 days to APP/PS1 mouse models. RESULTS: Urolithin A ameliorated cognitive deficits, prevented neuronal apoptosis, and enhanced neurogenesis in APP/PS1 mice.Urolithin A attenuated Aβ deposition and periplaque microglia and astrocyte hyperplasia in the cortex and hippocampus. Urolithin A affects key cell signaling pathways, particularly by enhancing brain AMPK activation, decreasing activation of P65NF-κB and P38MAPK, and inhibiting degradation of Bace1 and APP.
• In Vitro:
  METHODS: Human colorectal cancer cells SW620 were treated with Urolithin A (0-30 µM) for 24 h. Cell viability was measured by MTT assay. Results: A dose-dependent decrease in proliferation was observed in Urolithin A-treated cells. METHODS: Human colorectal cancer cells HT29, SW480 and SW620 were treated with Urolithin A (20-100 µM) for 48 h, an the expression levels of target proteins were detected by Western Blot. Results: Treatment of CRC cells with different concentration of Urolithin A resulted in a significant increase in Cyclin B1 and CDK6, suggesting a strong cell cycle accumulation in G2/M phase.

Storage & Handling

• Storage: keep away from direct sunlight | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
• Disclaimer: For research use only

Alternative Names

Urolithin A, Reactive Oxygen Species, Endogenous Metabolite, inhibit, Inhibitor, apoptosis, Apoptosis, autophagy, Autophagy, DNA/RNA Synthesis, DNA synthesis, Drug Metabolite

Compound Identifiers

PubChem CID

5488186